Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy, Ph.D. as Chief Scientific Officer [Yahoo! Finance]
Korro Bio, Inc. (KRRO)
Company Research
Source: Yahoo! Finance
EVANSTON, Ill., January 14, 2026 BUSINESS WIRE )--Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr. Krishnamurthy is an accomplished scientific and executive leader with more than 15 years of experience developing RNA therapeutics, bringing deep expertise in oligonucleotide chemistry, drug delivery, and advancing genetic medicine programs from discovery through clinical development. "We are thrilled to welcome Venkat to the Flashpoint executive team," said Barry Labinger, Chief Executive Officer of Flashpoint Therapeutics. "Venkat's proven leadership and remarkable track record of translating complex science into clinical stage medicines is a perfect fit for our mission. His deep expertise across multiple modalities will be instrumental as we accelerate the development of our proprietary structural nanomedicine platform and build a p
Show less
Read more
Impact Snapshot
Event Time:
KRRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRRO alerts
High impacting Korro Bio, Inc. news events
Weekly update
A roundup of the hottest topics
KRRO
News
- Korro Bio (NASDAQ:KRRO) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Korro to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Korro Bio (KRRO): Assessing Valuation After Clinical Setbacks, Layoffs, and Strategic Pivot [Yahoo! Finance]Yahoo! Finance
- Korro Bio (NASDAQ:KRRO) had its "hold" rating reaffirmed by analysts at Jones Trading.MarketBeat
KRRO
Earnings
- 8/12/25 - Miss
KRRO
Sec Filings
- 1/15/26 - Form 8-K
- 1/5/26 - Form SCHEDULE
- 12/18/25 - Form 8-K
- KRRO's page on the SEC website